Print
Email
ShareReinventing the World Health Organization
The World Health Assembly in Geneva this week needs to do more to define a workable mission for the struggling World Health Organization.
See more in International Organizations, Global Health
Senior Fellow for Global Health, Economics, and Development
International law and regulatory policy, tobacco and non-communicable diseases, technological innovation and delivery, international trade and investment, intellectual property, clinical trials, import safety.
Global Health Program, Maurice R. Greenberg Center for Geoeconomic Studies, Program on Science and Technology
The World Health Assembly in Geneva this week needs to do more to define a workable mission for the struggling World Health Organization.
See more in International Organizations, Global Health
The main health threat in developing states today is not plagues or parasites but illnesses such as cancer and diabetes, noncommunicable diseases long associated with the rich world.
See more in Economics, Global Health
Thomas Bollyky argues that the main health threat in developing states today is noncommunicable diseases long associated with the rich world, and the best way for the West to help is by pushing for governance reform.
See more in Global Health, Health and Disease
CFR Senior Fellow Thomas J. Bollyky and the Center for Global Development's director of global health policy Amanda Glassman propose using an innovative incentive mechanism, Cash-on-Delivery (COD) Aid, to improve tobacco control in developing countries.
See more in India, Global Health
Thomas J. Bollyky discusses President Obama's nomination of Jim Yong Kim to lead the World Bank.
See more in World Bank
The winner of the 2012 presidential election faces an important leadership test on trade, which will have challenges and opportunities, says CFR's Thomas Bollyky, including leveling the playing field with China and finalizing the Trans-Pacific Partnership.
See more in United States, U.S. Election 2012
Thomas Bollyky examines strategies to improve access to neglected disease treatments and sustainably meet the treatment needs of the world's poorest people.
See more in Health, Science, and Technology, Global Health
The 2011 high-level UN meeting on non-communicable diseases fell far short of the major funding and targets agreed to at a similar meeting on HIV/AIDS a decade ago, which CFR's Thomas Bollyky says indicates a need for different actors and approaches on chronic diseases.
See more in Global Health, Health and Disease
Tobacco is reemerging as a polarizing issue in U.S. trade policy. New trade agreement negotiations are forcing the White House to choose between the tobacco debate's partisans. This policy innovation memorandum proposes a new strategy by which the Obama administration can better balance U.S. mandates on trade policy on tobacco with its interests in promoting global health and U.S. standing abroad.
See more in United States, Asia, Trade, Global Health
Thomas J. Bollyky discusses tobacco's reemergence as a polarizing issue in U.S. trade policy.
See more in Trade, Global Health, Drugs, U.S. Strategy and Politics
1777 F Street, NW
Washington, District of Columbia 20006
CFR Senior Fellow for Global Health, Economics, and Development
+1.202.509.8517
| Jerusha Murugen |
For the first time, the top spot at the World Bank may not go to an American. Two candidates vying for the presidency represent developing nations.
Business News Network interviews Thomas Bollyky, Senior Fellow for Global Health, Economics, and Development, along with Lant Pritchett, Professor of International Development at the Harvard Kennedy School of Government, and Wilson Prichard, Professor of Political Science at the University of Toronto.
Tom Bollyky discusses Dr. Jim Kim's qualifications and future strategies for leading the World Bank as its 12th president.
